Tirzepatide Shows Promise in Preventing Diabetes with Long-Term Efficacy
TL;DR Summary
The article discusses the potential use of Ozempic, a medication primarily used for treating type 2 diabetes, as a preventive measure for diabetes. It explores the benefits and implications of using Ozempic for diabetes prevention, considering its effectiveness and the broader impact on health policy and patient care.
- Ozempic Could Prevent Diabetes. Should We Use It For That? The New York Times
- Eli Lilly's weight-loss drug helps nearly 99% of patients remain diabetes-free Reuters
- Treatment with tirzepatide in adults with pre-diabetes and obesity or overweight resulted in sustained weight loss and nearly 99% remained diabetes-free at 176 weeks Investors | Eli Lilly and Company
- Lilly unwraps detailed data showing tirzepatide kept nearly 99% of prediabetic patients diabetes-free over 3 years FiercePharma
- Eli Lilly's Tirzepatide Reduces Type 2 Diabetes Risk by 94% in Long-Term Study Yahoo Finance
Reading Insights
Total Reads
0
Unique Readers
1
Time Saved
0 min
vs 1 min read
Condensed
-66%
29 → 48 words
Want the full story? Read the original article
Read on The New York Times